Profile: Lannett Company Inc (LCI.A)
9 Dec 2013
Lannett Company, Inc. incorporated on March 12, 1991, is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company’s products manufactured and/or sold are prescription products. The Company’s products containing Levo are produced and marketed with 12 varying potencies. In addition to generic Levo tablets, the Company also markets and distributes Unithroid tablets, a branded version of Levo, which is produced and marketed with 11 varying potencies. The Company’s Levo tablets are used to treat hypothyroidism and other thyroid disorders. The Company’s generic Levo tablets and Unithroid tablets are manufactured by Jerome Stevens Pharmaceuticals (JSP). As of June 30, 2012, the Company manufactured and/or distributed 30 products.
Digoxin tablets are produced and marketed with two different potencies. This product is manufactured by JSP and the Company distributes it under the JSP Distribution Agreement. Digoxin tablets are used to treat congestive heart failure in patients of various ages and demographic backgrounds. The Company distributes two products containing Butalbital. The Company has manufactured and sold one of the products, Butalbital with Aspirin and Caffeine capsules. The other Butalbital product, Butalbital with Aspirin, Caffeine and Codeine Phosphate capsules, is manufactured by JSP. Both Butalbital products, which are in orally administered capsule dosage forms, are prescribed to treat tension headaches caused by contractions of the muscles in the neck and shoulder area and migraines. The drug is prescribed primarily for adults of various demographic backgrounds.
Morphine Sulfate Oral Solution is produced and marketed in three different size containers. The Company manufactures these solution dosage forms at its Cody Labs subsidiary. This drug is prescribed primarily for the management of pain in adults where other products or delivery methods are not tolerable to the patient. Cocaine Topical Solution (C-Topical) is produced and marketed under a preliminary new drug application (PIND) in two different strengths and two different size containers. The Company manufactures these liquid dosage forms at its Cody Labs subsidiary. This drug is utilized primarily for the anesthetization of the patient during ear, nose or throat surgery. It also works as a vasoconstrictor.
As of June 30, 2012, the Company’s manufactured and/or distributed products includes Acetazolamide Tablets, Amantadine SoftGel Capsules, Butalbital, Aspirin and Caffeine Capsules, Butalbital, Aspirin, Caffeine with Codeine Phosphate Capsules, Clindamycin HCl Capsules, Danazol Capsules, Dicyclomine Capsules and Diethylpropion HCl IR and ER Tablets among others. The Company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups governmental entities and health maintenance organizations.
The Company competes with Watson Pharmaceuticals, Breckenridge Pharmaceutical, GlaxoSmithKline, Impax Labs, Westward Pharmaceuticals, Caraco, Par Pharmaceuticals, Mylan Laboratories, Sandoz, Ranbaxy Laboratories, Mallinckrodt, Roxane, Purdue, Abbott Laboratories, Monarch Pharmaceuticals, Mylan, Sandoz, Qualitest Pharmaceuticals, Amneal ,Impax, VersaPharm, Inc., Corepharma, Epic and Teva.
Lannett Company Inc
9000 State Road
PHILADELPHIA PA 19136